WO2004086044A1 - Sensor for detecting an analyte using silver nanoparticles - Google Patents
Sensor for detecting an analyte using silver nanoparticles Download PDFInfo
- Publication number
- WO2004086044A1 WO2004086044A1 PCT/IE2004/000047 IE2004000047W WO2004086044A1 WO 2004086044 A1 WO2004086044 A1 WO 2004086044A1 IE 2004000047 W IE2004000047 W IE 2004000047W WO 2004086044 A1 WO2004086044 A1 WO 2004086044A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nanoparticles
- sensor
- silver nanoparticles
- silver
- analyte
- Prior art date
Links
- 0 CCC(*C)N=O Chemical compound CCC(*C)N=O 0.000 description 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0034—Additives, e.g. in view of promoting stabilisation or peptisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0043—Preparation of sols containing elemental metal
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0545—Dispersions or suspensions of nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0551—Flake form nanoparticles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0553—Complex form nanoparticles, e.g. prism, pyramid, octahedron
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F2998/00—Supplementary information concerning processes or compositions relating to powder metallurgy
Definitions
- the invention relates to a sensor comprising silver nanoparticles.
- a biological, chemical or biochemical sensor is a device capable of quantitative or qualitative recognition of a target species of interest, for example peptides, metabolites, molecules or ions
- ELISA enzyme-linked immunosorbent assay
- LFT lateral flow test
- diagnostic methods used for detection for example, titration, oxygen demand tests, chromatography, atomic absorption, spectroscopy/colorimetry.
- the surface plasmon mode is 'restricted' due to the small dimensions to which the electrons are confined, i.e. the surface plasmon mode must conform to the boundaries of the dimensions of the nanoparticle.
- the resonance frequency of the surface plasmon oscillation of the metal nanoparticle is different from the plasma frequency of the bulk metal.
- Surface interactions can alter the optical properties and influence the spectral profile of the light scattered by the SPR of the metal nanoparticles. This feature can be applied as an indicator in sensing interactions.
- silver nanoparticles have an especially strong SPR and are expected to provide particularly high sensitivity for biosensing purposes.
- Gold is the primary metal nanoparticle currently being researched for the development of bio-sensors. Since the late 1990s, a major area of research has been the development of DNA-based methods using gold nanoparticles [1-4].
- the colour change which may be observed in the presence of a target analyte is caused primarily by aggregation rather than a change in SPR.
- the individual gold nanoparticles may be functionalised such that the analyte causes them to aggregate, giving rise to a colour change; whereas discrete gold nanoparticles appear crimson in colour to the naked eye, larger aggregates of gold nanoparticles appear blue.
- the invention also relates to a method for the preparation of silver nanoparticles with controlled optical properties.
- this method uses a simple 'wet chemistry' technique for the easy production of large quantities of silver nanoparticles in a range of colours.
- nanoparticles such as colour or luminescence
- metal nanoparticles are known to behave as catalysts.
- a catalyst may be defined as an agent that increases the rate at which a chemical reaction occurs.
- different surfaces have different catalytic properties.
- Nanoparticles of different shapes also have different crystal surfaces, each of which may be expected to exhibit specific catalytic properties.
- enhanced catalytic efficiency is anticipated from such shaped nanoaprticles. While considerable progress has been made in the development of synthetic methods that afford control of nanoparticle size, control of nanoparticle morphology has proved more difficult to achieve. Only a few methods for the preparation of silver nanoparticles having defined shapes have been reported. However, many of these methods have limitations which would impede their application to the bulk production of silver nanoparticles.
- a technique reported by Zhou et al uses ultraviolet irradiation and poly (vinyl alcohol) (PVA) as a stabilizer to synthesize silver nanorods of length up to 350 nm (9). Such photo induced methods are expensive, often requiring long irradiation times of up to 70 hours.
- PVA poly (vinyl alcohol)
- Murphy et al 10-10 described a seeding method to obtain silver nanorods of controllable aspect ratio and lengths ranging from 40 nm to 200 nm.
- Cetyltrimethyl ammonium bromide (CTAB) was used to template the growth of the nanorods.
- the silver nanorods showed two plasmon bands in the UV-Vis absorption spectrum - one at 400 nm and another at wavelengths ranging from 900 to 1100 nm depending on the length of the nanorods.
- the widely used CTAB is not efficient as a stabilising agent as it is only water soluble at elevated temperatures. This poses problems for the long term stability and storage of nanomaterials produced according to this method.
- Mirkin et al (7) developed a photo-induced method to prepare silver nanoprisms of edge length 100 nm by irradiation of spherical silver nanoparticles. These nanoprisms showed three plasmon resonances - at 335, 470 and 670 nm. However, this method requires irradiation conditions involving light of a specific wavelength range and requiring irradiation times of up to 125 hours.
- NSL is a complex and costly technique, and is as yet only a laboratory procedure which is not industrially proven.
- the primary disadvantage of this method in its application to bio-sensing is that the available sensing surface area of the silver nanoparticles is reduced due to the inactivity of the surface area bound to a solid substrate.
- being bound to a substrate greatly reduces the flexibility of these nanoparticles for use in bio-sensing applications.
- the present invention is directed towards a detection method which overcomes many of these problems.
- a sensor comprising silver nanoparticles in which substantially all of the surfaces of the silver nanoparticles are available for interaction with an analyte or for functionalisation with a receptor which is capable of interacting with an analyte.
- a receptor specific to a target analyte is attached to the surface of the nanoparticles.
- the receptor may be bonded directly to the surface of the nanoparticles.
- a linker is provided between the receptor and the silver nanoparticles.
- the linker incorporates an organic or an inorganic functional group.
- the functional group may comprise a thiol group or an amine group.
- More than one type of receptor may be attached to the silver nanoparticles.
- the silver nanoparticles are stable, shaped and substantially platelike in structure.
- the silver nanoparticles have dimensions in the range of from 5 to 100 nm.
- the silver nanoparticles may have dimensions in the range of from 18 nm to 32 nm.
- the morphology of at least some of the silver nanoparticles is hexagonal and/or triangular in shape. At least some of the silver nanoparticles may display an SPR peak in the 400 nm region. At least some of the silver nanoparticles may display an SPR peak in the 470 to 600 nm region. At least some of the silver nanoparticles may display an SPR peak in the 340 nm region.
- the silver nanoparticles show predominantly non-spherical morphology.
- the silver nanoparticles are immobilised on a permeable substrate.
- the silver nanoparticles are disposed on a film.
- the silver nanoparticles are formed into a predetermined body.
- the silver nanoparticles may be cast, pressed or moulded into a body.
- the nanoparticles are in a solvent system.
- the solvent system may be an aqueous based system.
- the invention provides a method for detecting an analyte comprising contacting the analyte with a sensor of the invention and observing a detectable change.
- the detectable change may be a change in the absorption spectrum.
- the detectable change may be a qualitative or quantitative change.
- the change is a colour change observable with the naked eye.
- the change in the absorption spectrum is a shift which is detected in the range from 200 nm to 900 nm.
- the shift is preferably from 1 to 150 nm.
- the shift may be from 5 to 50 nm.
- the invention provides a method for preparing silver nanoparticles which comprises the step of forming the nanoparticles in the presence of a polymeric stabiliser.
- the method comprises the step of controlling the optical response of the silver nanoparticles by varying the concentration of the polymeric stabiliser.
- the polymeric stabiliser has a molecular weight of greater than 10 kDa.
- the molecular weight of the polymeric stabiliser may be less than 1300 kDa.
- the polymeric stabiliser is water soluble.
- the polymeric stabiliser is selected from one or more of poly (vinyl alcohol), poly(vinylpyrollidone), poly(ethylene glycol), and poly(acrylic acid).
- the polymeric stabiliser is poly (vinyl alcohol).
- the method comprises reducing a silver salt.
- the silver salt may be silver nitrate.
- the reaction is carried out in the presence of seed silver nanoparticles.
- reaction is carried out in the presence of seed silver nanoparticles.
- the ratio of [silver nitrate] to [silver seed] may be greater than or equal to 50:1.
- the ratio of [silver nitrate] to [silver seed] is between 50:1 and 200:1. Typically the ratio of [silver nitrate] to [silver seed] is between 50:1 and 100:1.
- reaction is carried out in an aqueous medium.
- the reduction may be carried out at a temperature of from 10 °C to 60 °C, typically the reduction is carried out at a temperature of about 40 °C.
- the reaction is carried out in the dark, or the reaction may carried out in ambient light conditions, or the reaction may be carried out under controlled irradiation conditions.
- the invention also provides nanoparticles when made by the method of the invention. These may be used for example in a sensor as hereindescribed.
- the invention provides silver nanoparticles wherein the nanoparticles are between 5 and 100 nm in size.
- the particles may show predominantly non-spherical morphology.
- the nanoparticles are between 10 and 50mm in size.
- the nanoparticles have an average size of 31nm ⁇ 8nm. In another case the nanoparticles have an average size of 20nm ⁇ 8nm.
- the nanoparticles have an average size of 22nm ⁇ 8nm.
- the invention also provides the use of silver nanoparticles in any one or more of sensing, biosensing, imaging, data storage, catalysis.
- Fig. 1(a) shows a typical UV- visible absorption spectrum (hereinafter, 'spectrum') of spherical nanoparticles having a surface plasmon resonance (SPR) maximum absorption around 408 nm and being yellow in colour;
- Fig. 1(b) is a transmission electron micrograph (TEM) of the spherical nanoparticles of Fig. 1(a);
- Fig. 2(a) shows a typical spectrum for a mixture of nanoparticles which is red in colour and contains a mixture of spherical and triangular and hexagonal shaped nanoparticles.
- the SPR maxima are located around 419 nm and 509 nm;
- Fig. 2(b) is a TEM of the mixture of nanoparticles of Fig. 2a having spherical, triangular and hexagonal morphologies;
- Fig. 3(a) shows a typical spectrum for a mixture of silver nanoparticles having only triangular and hexagonal morphologies, having an SPR peak at 498 nm and being red in colour;
- Fig. 3(b) is a TEM of the mixture of triangular and hexagonal nanoparticles of Fig. 3(a);
- Fig. 4(a) shows typical spectra of batches of silver nanoparticle samples prepared under varying reaction conditions illustrating a variation in the position of the second plasmon band depending on the choice of reaction conditions.
- Spectrum A is associated with triangular nanoparticles which appear red in colour to the naked eye.
- Spectrum B is associated with a mixture of triangular and hexagonal nanoparticles which appear purple in colour.
- Spectrum C is associated with hexagonal nanoparticles which appear blue in colour.
- Spectrum D is associated with spherical nanoparticles which appear yellow in colour;
- Fig. 4(b) shows TEM of the predominant nanoparticle shape associated with the absorption spectra shown in Fig. 4(a);
- Fig. 5 shows a typical spectrum of a mixture of silver nanoparticles containing spherical, triangular and hexagonal morphologies which were produced in darkness;
- Fig 6(a) a typical spectrum of silver nanoparticles produced according to the method described by Sun et al;(16)
- Fig. 6(b) shows TEM of the nanoparticles of Fig. 6(a);
- Fig. 7 shows a typical spectrum of gold nanoparticles which are red in colour
- Fig. 8 shows a typical spectrum of gold nanoparticles which undergoes a spectral shift of 0.5nm upon addition of dimethyl sulf oxide (DMSO);
- DMSO dimethyl sulf oxide
- Fig. 9 shows a typical spectrum of silver nanoparticles which undergoes a spectral shift of llnm upon addition of DMSO;
- Fig. 10 shows a spectrum of silver nanoparticles produced according to the method of Sun et al which undergoes a spectral shift of 6nm upon addition of DMSO;
- Fig 11 shows a typical spectrum of a mixture of spherical, triangular and hexagonal silver nanoparticles whose SPR absorption maximum is shifted to shorter wavelengths in response to the presence of l-ethyl-3-(3- dimethylaminopropy -carbodiimide (EDC) ;
- Fig. 12 shows typical spectra of silver nanoparticles at the time of preparation and after 8 months
- Fig. 13(a) is a schematic representation of a sensor of the invention consisting of silver nanoparticles bearing a receptor (i) and the interaction of the sensor with a target analyte (ii);
- Fig. 13(b) is a schematic respresentation of a sensor of the invention consisting of silver nanoparticles bearing receptors for two or more target analytes and the interaction of the sensor with the target analytes;
- Fig. 13(c) is a schematic respresentation of a sensor of the invention consisting of two or more batches of silver nanoparticles, each bearing a receptor for a target analyte, immobilised on a permeable solid surface, and the interaction of the sensor with the target analytes
- Fig. 13(d) is a schematic respresentation of a sensor of the invention consisting of two or more batches of silver nanoparticles, each bearing a receptor for a target analyte, in a liquid medium, and the interaction of the sensor with the target analytes;
- Fig. 14 is a series of normalised spectra recorded at each stage in preparing a sensor of the invention using spherical silver nanoparticles. The spectra of the nanoparticles upon the addition of a thiol layer and after functionalisation with biotin are compared;
- Fig. 15(a) is a series of normalised spectra recorded at each stage in preparing a typical sensor of the invention to detect streptavidin.
- the spectra of a mixture of spherical, triangular and hexagonal nanoparticles before and after functionalisation with biotin and following centrifuging and resuspension are compared;
- Fig. 15(b) illustrates an SPR shift of 7 nm for the sensor of Fig. 15(a) in response to streptavidin at a concentration of 5 ⁇ g/ml;
- Fig. 16 is a plot of the shift in SPR of another sensor of the invention in response to streptavidin at concentrations ranging from 10 ng/ml to 0.1 mg/ml. A linear fit to the data was obtained in the range 10 ng/ml to 10 ⁇ g/ml;
- Fig 17 is a series of normalised spectra showing the response of a typical sensor of the invention to detect streptavidin at concentrations ranging from 100 pg/ml to 0.1 mg/ml.
- the qualitative limit of detection for streptavidin is 10 pg/ml; a linear response is obtained in the range 1 ng/ml to 1 ⁇ g/ml;
- Fig. 18 shows a plot of the shift in SPR of the sensor of Fig. 17 to streptavidin at concentrations ranging from 100 pg/ml to 10 ⁇ g/ml.
- a linear fit to the data was obtained in the range 1 ng/ml to 100 ng/ml;
- Fig 19 is a spectrum of a mixture of spherical, triangular and hexagonal silver nanoparticles whose SPR absorption maxima at 417 nm and 502 nm are each shifted to longer wavelengths at 427 and 512 nm respectively in response to streptavidin;
- Fig 20 is a typical spectrum of a mixture of triangular and hexagonal silver nanoparticles whose SPR absorption maximum at 493 nm is shifted to a shorter wavelength at 484 nm in response to BSA at a concentration of 10 mg/ml.
- Fig. 21(a) shows the evolution of the SPR spectral shift in response to binding of Bovine Serum Albumin (BSA) onto the nanoparticle surface over time;
- BSA Bovine Serum Albumin
- Fig. 21(b) shows a plot of SPR response and the changes in absorption of the nanoparticles of Fig 21(a) in response to the adsorption of BSA with time;
- Fig 22. shows a typical spectrum of a mixture of spherical, triangular and hexagonal silver nanoparticles whose SPR absorption maximum at 527 nm is shifted to 509 nm in response to 10 mg/ml BSA in the presence of l-ethyl-3-
- Fig 23. is a schematic of an embodiment of sensor of the invention in the format of a lateral flow test for domoic acid. The performance of the sensor of the invention using silver nanoparticles is compared with using gold nanoparticles as detailed in example 9;
- Fig 24(a) shows a typical series of normalised spectra at various stages in the preparation of a sensor of the invention for the detection of anti-IgG;
- Fig 24(b) shows the typical response of the sensor of Fig 24(a) to anti-IgG at a concentration of 0.1 ⁇ g/ml. An SPR shift of 21 nm is observed.
- Fig. 25 is a schematic representation of an embodiment of the sensor of the invention whereby the sensor is immobilised on a permeable solid surface;
- Fig 26 shows a solid-state silver nanoparticle sensor before (b) and after (a) addition of DMSO;
- Fig. 27 is a schematic representation of an embodiment of the sensor of the invention in the format of a handheld device.
- the device as it would appear to the user is depicted in (a), while the components required to construct such a device are illustrated in (b); and
- Fig. 28 is a schematic representation of a further embodiment of the sensor of the invention in the format of a rapid assay kit.
- the invention provides a sensor comprising silver nanoparticles for detecting an analyte.
- the invention also provides a sensor comprising silver nanoparticles having a detection means attached thereto wherein the silver nanoparticles provide a detectable change in their UV-visible absorption spectrum in response to the binding of an analyte. This change may be observed by instrument or by the naked eye.
- Metal nanoparticles are small enough to interact intimately with biological or chemical species. Such interaction is facilitated by their comparable size and by the large surface area to volume ratio of the nanoparticles. Molecular species can be readily attached to the nanoparticle surface. The attachment, which can be by nonspecific adsorption or interactions involving covalent or electrostatic bonding, affects the SPR of the nanoparticle and alters the spectral response.
- This alteration of the spectral response can be observed either as a wavelength shift in spectral peak, a diminishment or enhancement of the peak absorbance, or a combination of these.
- This sensitivity of the surface of these nanoparticles to the molecules in the surrounding environment makes them ideal for sensor applications.
- the most typical metal nanoparticle shape is spherical and these have a characteristic single SPR spectral peak. If a metal nanoparticle has a non-spherical shape, for example ovoid, then the SPR will exhibit more than one peak. This occurs as the nanoparticles are no longer isometric and the SPR electrons have more than one oscillation axis. In the case of ovoid nanoparticles, electronic oscillation about the major and minor axes will result ih at least two peaks in the SPR spectrum.
- non-isometric metal nanoparticles are their increased sensitivity, which in part arises from the presence of the additional SPR spectral peaks. Since the most energetically favourable nanoparticle morphology is spherical, the additional SPR peaks of non- spherical nanoparticles are therefore extra-sensitive to the local environment, and changes in the spectral profile are more easily observable than in the case of single SPR peak spherical metal nanoparticles.
- Silver nanoparticles are preferable to gold. This is due to the stronger and more distinctive SPR spectrum of silver nanoparticles, as may be seen by comparing Fig. la with Fig. 3a, meaning that they exhibit a far more sensitive response. However it has not been possible to prepare them in a stable and useable format, until very recently.
- the method described herein enables the preparation of a range of silver nanoparticles having various colours and shapes in solution which are stable over long time periods and do not aggregate.
- Substantially all of the surfaces of the silver nanoparticles are available for interaction with an analyte or for functionalisation with a receptor which is capable of interacting with an analyte because the nanoparticles can be produced in a solvent based system such as an aqueous medium rather than by a deposition process.
- (c) A mixture of spherical, triangular and hexagonal shaped silver nanoparticles which appear purple in colour to the naked eye.
- the average diameter of the spherical particles is 22 ⁇ 8 nm
- the average edge length of the triangular particles is 22 ⁇ 8 nm
- the average distance between opposite faces of the hexagonal particles is also is 22 ⁇ 8 nm.
- This mixture of particles displays two absorption bands. One occurs in the range 405 to 420 nm and is associated with the presence of spherical silver nanoparticles.
- the second band occurs in the range 530 to 550 nm and is associated with the presence of triangular and hexagonal silver nanoparticles.
- the average edge length of the triangular particles is 56 ⁇ 7 nm; the average distance between opposite faces of the hexagonal particles is also 56 + 7 nm.
- This mixture of particles displays one absorption band which occurs in the region 490 to 510 nm.
- particles may be produced consisting of triangular shapes only, hexagonal shapes only or a mixture of triangular and hexagonal shapes, having a single plasmon band which is tuned to occur in the range of about 450 nm to about 650 nm.
- This sample contains spherical silver nanoparticles and truncated triangular nanodisks of silver. The average size of these particles is 27 ⁇ 5.5 nm. This sample displays two plasmon bands. The first band occurs in 410 to 420 nm region. The second band occurs in the
- the method can be tuned to produced nanoparticles of a narrow size distribution with various shapes.
- the advantage of a narrow size distribution is that the band width of the absorption spectrum will also be narrow, for example
- the silver nanoparticles may be stabilized by polymeric stabilizers of a range of molecular weights greater than 10 kD and less than 1300 kD.
- the silver nanoparticles may be stabilized by a range of water-soluble polymeric stabilizing agents including but not restricted to poly (vinyl alcohol) (PVA), poly(vinylpyrollidone) (PVP), ⁇ oly(ethylene glycol) (PEG), or poly(acrylic acid)
- the stabilizer used to prepare the silver nanoparticles is PVA; most preferably, the stabilizer is PVA having molecular weight ranging from 89 kD to 98 kD.
- the molar ratio of silver ion to silver seeds influences the final size of the nanoparticles.
- the appearance of the cornered particles is only observable above a certain nanoparticle size (c. 20 nm).
- Silver nanoparticles may be prepared using a ratio of ion to seeds ranging from 10:1 to 400:1, more preferably 50:1 to 400:1 and most preferably 100:1. The higher the ratio of ion to seeds, the larger the nanoparticle size obtained.
- Figs, la and lb relate to spherical nanoparticles only.
- Figs. 2a and 2b relate to a mixture of spherical, triangular and hexagonal nanoparticles.
- Using nanoparticles which are a mixture of spheres and cornered nanoparticles is useful since the cornered nanoparticles are more sensitive than the spherical ones.
- the ratio of the changes induced in SPR peaks of the two types of nanoparticles can provide important information for sensing.
- Figs. 3(a) and 3(b) relate to triangular and hexagonal nanoparticles only.
- the absence of a peak in the 410 nm region indicates the absence of spherical nanoparticles as is confirmed by the TEM image in Fig 3(b).
- cornered nanoparticles are especially advantageous due to their very high sensitivity.
- Fig. 4(a) shows spectra of nanoparticles produced by the synthetic method of the invention demonstrating that this method can be used to prepare silver nanoparticles of a variety of colours, ranging from red to purple to blue. This is carried out through variation of the reaction conditions; particularly the concentration of stabilising agent used. This allows of the position of the long wavelength SPR band to be tuned. The SPR band position is dependent on the predominant nanoparticle shapes present in a sample.
- Fig. 4(b) illustrates the predominant nanoparticle morphology associated with each sample in Fig. 4(a).
- Fig. 5 shows a spectrum of silver nanoparticles of spherical and truncated triangular morphology which were prepared in the absence of irradiation and ambient light.
- the silver nanoparticles of Fig. 5 were prepared by carrying out the reaction in a darkroom.
- Silver nanoparticles were also prepared by an alternative method as described by Sun et al [16]. This method requires a length reflux period of greater than 10 hours.
- the spectrum of the silver nanoparticles as shown in Fig 6(a) shows main peak at 463 nm with a second feature in the region of 347 nm which is typically expected of silver triangular nanoplates.
- the TEM shown in Fig 6(b) confirms the presence of shaped nanoparticles, including triangles and hexagonal morphologies.
- the nanoparticles produced by the Sun method show a wide dispersion of sizes with nanoparticle diameters ranging from about 10 nm to larger than 100 nm observed in the same sample. A significant degree of aggregation is also observable in the TEM image, which is considered as disadvantageous property of nanoparticles. This is again in contrast to the silver nanoparticles produce by the method described herein.
- Fig. 10 the SPR response of the silver nanoparticles produced by the Sun method is demonstrated.
- DMSO a 6 nm shift to longer wavelengths is observed in a similar manner to that which occurs in the case of the silver nanoparticles produced by the method described here in.
- the SPR response is also given by silver nanoparticles produced by alternative methods and hence that such silver nanoparticles may also be used for sensing purposes.
- Figs. 8 and 9 demonstrate the enhanced sensitivity of silver nanoparticles over gold nanoparticles.
- the silver nanoparticles exhibit an 11 nm shift in response to dimethyl sulfoxide (DMSO) whereas a shift of only 0.5 is found in the case of gold.
- DMSO dimethyl sulfoxide
- Fig. 11 demonstrates the detection of the molecule N-(3-Dimethylaminopropyl)-N'- ethylcarbodiimide hydrochloride (EDC) by a silver nanoparticle based sensor of the invention.
- EDC N-(3-Dimethylaminopropyl)-N'- ethylcarbodiimide hydrochloride
- the silver nanoparticles of the invention are easily synthesised in a stable form and remain stable over time.
- the silver nanoparticles are synthesised in solution.
- the stability of the nanoparticles is illustrated in Fig. 12. Little change is observed in the relative intensity and the profile of the absorption of the plasmon bands after 8 months. A small blue shift of only 5 nm in the position of the peak maximum of the band at 500 nm is found.
- the lack of aggregation or precipitation of the nanoparticles and the consistency of the spectrum over time indicates the very high long term stability of the silver nanoparticles of the invention. It is noted that the silver nanoparticles of the invention do not aggregate or exhibit aggregation problems in the manner typically experienced when working with both metallic and non metallic nanoparticles.
- Molecular species may be readily attached to the surface of the nanoparticles, for example in the form of a self -assembled monolayer (SAM), and the surface interaction generates a change in the nanoparticles' absorption spectrum. This change may be observed as a colour change visible to the naked eye, or as a shift or change in intensity in the spectrum, and may be used as an indicator in detecting a target analyte.
- SAM self -assembled monolayer
- a receptor molecule capable of recognising the target analyte may be attached to the silver nanoparticle surface. Upon interaction with the target molecule, the nanoparticle-receptor system generates a change in the nanoparticles' spectrum which serves to indicate that detection of the target analyte has taken place.
- the rate at which the receptor and analyte interact is the rate at which the receptor and analyte interact.
- the profile of the spectrum obtained as shown in Fig. 14 (spherical nanoparticles) and Fig. 15(a) (spherical, triangular and hexagonal nanoparticles) for the example of detection of a streptavidin target by a biotin receptor, does not alter over time.
- the rate at which the interaction occurs may be determined by observing the change in the spectrum during the course of the interaction.
- Fig. 14 shows the attachment of a layer of carboxyl ended thiol molecules (mercaptoundecanoic acid) to spherical silver nanoparticles and the subsequent coupling of amine terminated biotin molecules to the silver nanoparticle surface to form a sensor for streptavidin.
- the sensor's response to an analyte is reproducible for concentrations of target analyte over a broad range.
- a response in the case of streptavidin, is shown in Table 1.
- Existing methods are sensitive only at low concentrations of analyte.
- ELISAs typically operate at concentration in the range of 1 ⁇ g/ml to 200 pg/ml, exceptionally to 10 pg/ml, but are not able to provide reproducible responses outside this range of concentrations.
- a pre-treatment stage is usually required in conducting an ELISA and in the case of unknown samples, repeated analysis cycles are frequently required.
- the basic construction of the sensor includes a receptor which interacts selectively with a target analyte and an indicator which generates a signal when an interaction has occurred.
- the silver nanoparticles are used as the indicator component. Any suitable recognition system may be used as the detector and target components. Additionally more than one type of receptor may be attached to the nanoparticles such that the sensor would be capable of detecting more than one target analyte simultaneously.
- Biotin was used as the receptor, and streptavidin as the target.
- Fig. 13(a) shows the construction of the sensor schematically.
- the receptor molecule may be attached to the silver nanoparticles via, for example, a thiol or amine group. This group may be part of the receptor molecule's chemical structure or may be introduced through the use of a linker molecule, as follows:
- a biotin and a thiol may be coupled to each other first prior to attachment to the silver nanoparticles.
- a thiol linker was first attached to the silver nanoparticles. The resulting silver nanoparticles bearing a thiol monolayer were then incubated with biotin solution, resulting in the formation of a biotinylated monolayer on the surface of the silver nanoparticles.
- Figs. 13(b)-(d) is a schematic showing the construction of a sensor capable of detecting two or more target analytes simultaneously.
- 13(b) shows that receptors for two or more target analytes may be deposited on the same batch of nanoparticles.
- the resulting sensor will generate a response when one or more target analyte is present in the sample matrix. This cannot be achieved at present using gold nanoparticles because the aggregation process responsible for the colour change observed in gold-based assays requires higher concentrations of analyte.
- Fig. 13(c) shows that multiple sensors may be prepared, each consisting of a separate batch of nanoparticles with a receptor for a different target analyte deposited on each batch. Each sensor is deposited on the same porous substrate e.g.: nitrocellulose membrane. The sample is applied to each sensor and the response of each sensor to the sample is measured concurrently.
- a porous substrate e.g.: nitrocellulose membrane.
- Fig. 13(d) shows the preparation of multiple sensors, each consisting of a separate batch of nanoparticles with a receptor for a different target analyte deposited on each batch such that each sensor thus produced exhibits a discrete absorption peak in the UV-visible spectrum.
- An aliquot of each sensor is combined into a single solution; upon addition of the sample matrix, the absorption peak for the target analyte(s) present will shift. If one or more target analytes are not present in the sample matrix, no shift will be observed in the ⁇ eak(s) for their sensor(s) .
- the attachment of the receptor to the silver nanoparticles may be monitored by changes in the spectrum of the nanoparticles, as shown in Fig. 6(b) for the coupling of an amine-terminated biotin to spherical triangular and hexagonal silver nanoparticles.
- the biotinylated silver nanoparticles were then reacted with the target molecule, streptavidin.
- Fig. 14 and Fig. 15(a) show the spectra recorded at each stage in preparing the sensor of the invention for streptavidin using spherical nanoparticles and a mixture of spherical, triangular and hexagonal nanoparticle, respectively; the silver nanoparticles alone, the silver nanoparticles with biotin comprising the streptavidin sensor.
- Fig 15(b) shows the response of the biotinylated nanoparticles of Fig 15(a) to streptavidin at a concentration of 5 ⁇ g/ml. Reacting the silver with streptavidin leads to a further reduction in the peak at
- the sensor of the invention is able to detect a target molecule over a broad range of concentrations.
- Table 1 shows the response of silver nanoparticles biotinylated with 0.1 mM biotin to form a sensor for streptavidin to concentrations of streptavidin ranging from 0.1 mg/ml to 10 ng/ml.
- biotin was used as the receptor, and streptavidin as the target.
- the response generated by the sensor takes the form of a shift in the SPR maximum absorption in the UV-visible absorption spectrum (SPR Response).
- Fig. 16 shows a plot of the data in Table 1. The SPR response is found to be proportional to the concentration of the target, showing that the sensor of the invention may be used quantitatively.
- the linear fit of the data in Fig 16 indicates the region where this particular sensor of the invention gives a linear response to streptavidin concentrations (0.01 ⁇ g/ml to 10 ⁇ g/ml) and may be considered as the operational range of this particular sensor. As indicated by the data in Fig 16, the response of the sensor begins to saturate with concentrations of
- Fig 17 is a series of normalised spectra showing the response of another sensor of the invention for streptavidin to streptavidin concentrations ranging from 100 pg/ml to 10 ⁇ g/ml streptavidin.
- the SPR response for the sensor of Fig 17 is plotted in Fig 18.
- the silver nanoparticles of the invention are expected to have an overall negative charge. This charge can play a role in enabling large molecules such as proteins to bind to the silver surface.
- proteins a number of features including the net positive charge of a protein (lysine), together with hydrophobic binding (tryptophan) and sulphur bonding (cystine and methinine) can facilitate the attachment between the nanoparticle and protein. This enables proteins to be readily adsorbed onto the nanoparticle surface. Proteins may also be coupled onto the nanoparticles.
- trisodium citrate in preparing the nanoparticles means that carboxyl groups are present on the nanoparticle surface.
- BSA bovine serum albumin
- Streptavidin adsorption
- the distinctive response of silver nanoparticles to different molecules, in this case proteins, is illustrated herein where streptavidin adsorption is shown to induces a shift of the SPR peak to longer wavelengths as seen in Fig 19, while BSA induces a shift of the SPR peak to shorted wavelengths as seen in Fig 20.
- BSA bovine serum albumin
- centrifugation was used to remove excess unbound protein.
- the presence of BSA may be followed by its characteristic absorption peak in the 280 nm region as seen in
- Fig 20 It may be noted that the original silver has only a weak eature in this region of the spectrum. On adding the 10 mg/ml BSA solution saturation of the 280 nm feature occurs. After centrifugation, the presence of the attached BSA is indicated by the peak in the 280 nm region.
- Figs. 21(a) and 21(b) show the capacity of the silver nanoparticles to provide information on the rate of a reaction or interaction at their surface.
- Fig. 21 (b) shows the evolution of the SPR spectrum in response to the adsorbance of Bovine Serum Albumin (BSA) onto its surface over time.
- BSA Bovine Serum Albumin
- the SPR of the second peak which corresponds to cornered silver nanoparticles (triangles & hexagons) is originally located at 493 nm and throughout the course of the BSA adsorption the SPR maximum shifts by about 10 nm to 483 nm.
- a decrease in the absorbance of this peak is also observed where the absorbance changes from 1.14 mm “1 to 1.05 mm “1 which corresponds to a 7.9 % absorbance change.
- This example also illustrates the increased sensitivity of cornered silver nanoparticles over spherical silver nanoparticles.
- the spherical nanoparticles whose SPR is located in the 425 nm region show little detectable SPR shift in response to the BSA adsorption.
- An absorption change of 5.2 % is observed for the spherical nanoparticle peak.
- Fig. 21(b) shows the graph of the cornered nanoparticle SPR shift and absorption change with time.
- Protein coverage of the nanoparticles may be increased by using a coupling method such as carbodiimidecoupling.
- Fig 22 shows BSA coated nanoparticles as a result of using N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC). Again the 280 nm feature remains strong upon centrifugation indicating the binding to the BSA to the nanoparticle surface.
- EDC N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride
- Protein coating of silver nanoparticles may be used to construct sensors akin to ELISA or Lateral flow tests.
- the antibody /antigen coated silver nanoparticles become a sensor for the corresponding antigen or antibody.
- a silver nanoparticle sensor for Domoic Acid which can cause Amnesic Shellfish Poisoning (ASP) in humans, was constructed.
- Testing for domoic acid is typically carried out using an ELISA test.
- a lateral flow format was used for the test which demonstrates the usefulness of silver nanoparticles in this type of test format.
- Gold nanoparticles which are the typical material used for lateral flow tests, were used as a control test. The test is depicted in Fig 23.
- the receptor was domoic-acid antibody (anti-domoic acid), which was adsorbed on to the gold nanoparticle and EDC coupled onto the silver nanoparticles.
- the lateral flow strip consisted of a control line of rabbit anti-mouse which can bind non-specifically to anti-domoic acid and a test line with domoic acid conjugated to
- Fig 24(b) The optical format for a sensor of the invention for the antibody, anti-IgG is shown in Fig 24(b).
- Fig 24(a) shows a series of normalised spectra for various stages of the preparation of the anti-IgG sensor.
- the antigen IgG is used as the receptor.
- the response of the sensor to 0.1 ⁇ g of anti-IgG is shown in Fig 24(b) where a significant SPR shift of 21 nm is observed. An SPR shift of this magnitude corresponds to a colour change which is readily detectable with the naked eye.
- the selectivity of the sensor is achieved through the presence of a receptor which only allows interaction with the desired target analyte(s).
- a blocking method may be used to prevent possible interference caused by species present in the sample matrix interacting with the exposed silver surface. This blocking method involves binding an un-reactive layer (e.g.: albumin proteins) on to the receptor-coated nanoparticles. This principle is well known in the application of gold nanoparticle technologies.
- the sensor may also be used in a solid-state format, as illustrated in Fig. 25.
- the sensor of the invention was deposited on a nitrocellulose membrane whose pore size was chosen such that dilute solutions of the target analyte passed through the membrane while the sensor's nanoparticles remained trapped in its structure. Upon passing a solution of analyte through the membrane, the analyte interacts with the receptor present on the nanoparticles causing a detectable change in the spectrum.
- the sensor of the invention may be cast as a film from polymer solution.
- the sensitivity of the sensor By tailoring the chemical structure of the receptor and linker molecules, it is possible to control the sensitivity of the sensor to its target analyte. Hence, when used qualitatively, the sensor may be tailored to generate a positive response to its target analyte only above a predetermined concentration.
- the sensor of the invention is easy to use, even for unskilled operators, and may be developed as a rapid assay suitable for field use. Any suitable means for measuring the change in the abso ⁇ tion spectrum may be used e.g. spectroscopy or colour change visible to the naked eye.
- the senor of the invention would provide an alternative assay method to replace or complement conventionally used detection methods such as western blotting, direct enzyme assays, radioimmunoassays and enzyme-linked immunosorbent assays (ELISA).
- the sensor may be designed to detect different target analytes.
- the sensor may be designed to detect more than one analyte in the same assay.
- the sensor may be applied to the detection of biological, chemical and biochemical species in the field of clinical, chemical and environmental analysis.
- the sensor may be manufactured in the form of a hand-held device specific to certain targets of interest in biological, chemical and biochemical analysis.
- a schematic for such a hand-held device is depicted in Fig 27.
- Light-emitting diodes LEDs which may have a narrow spectral emission band width, for example, may be used as the light source for the detector.
- a small volume of sample solution is added to the sensor vessel, or cuvette, within the device.
- the cuvette may be a single-use component of the device.
- the instantaneous colour change which occurs in response to detection of the target analyte is measured by the photodiode which may also have a narrow spectral response range.
- the induced colour change corresponds to a change in the spectra transmission by sensor of the LED emission.
- the photodiode records the transmission change as a change in its signal voltage.
- the device may be calibrated to produce a qualitative or quantitative response to the target analyte.
- the signal voltage corresponding to detection of the analyte is used to illuminate a LED on the face of the device which the user observes as a "Yes" response.
- the device is constructed such that, in the absence of the analyte, a second LED is illuminated which the user observes as a "No" response.
- the device is calibrated such that the signal voltage varies in proportion to the concentration of analyte present.
- FIG 28 A schematic for another such a hand-held device is depicted in Fig 28.
- the hand-held device is a single-use kit.
- a small volume of sample solution is added to the test area containing the sensor which is embedded in a pad.
- a filtering system maybe used to remove sample material which is not of interest to the test.
- On removing the filter material the colour change response of the sensor to the detection of the target analyte is observed.
- the system is calibrated such that a reference card for the colour change corresponding to positive detection of a target analyte is provided for comparison by the user. Similarly the reference colour for the case where detection of the target analyte is absent is also provided.
- Portable spectrophotometers are commercially available for field use for chemical and environmental analysis. If detection of various analytes is required, the procedure must be repeated or each analyte of interest.
- the sensor of the invention may inco ⁇ orate two or more receptors in a single sensor, thereby allowing the operator to test for multiple analytes simultaneously.
- the sensor of the invention comprising silver nanoparticles has many other advantages over known detection methods. It provides quantitative and qualitative detection of an analyte. It is highly sensitive. It can give an instantaneous response. The degree of selectivity to the target is controllable. The sensitivity may be controlled to give a positive response above a threshold concentration.
- the sensor may be used as a multi-target sensor for detecting multiple analytes in a sample.
- the spectral response of the sensor may take the form of a colour change visible to naked eye.
- the sensor may be used in solution or the solid state. The sensor may also be used to monitor the rate of a reaction.
- the present invention provides a method for producing colloidal particles. More specifically, the invention provides a simple solution phase method for the production of large quantities of silver nanoparticles with defined shapes and consequently, particular optical properties. The control over the linear optical response of nanoparticles enables enhancement of their nonlinear response and has significant potential in optical technologies.
- the nanoparticles of the invention have great potential for a wide range of applications such as nanoscale sensing, biosensing, imaging and data storage (17-19).
- the invention provides a method for controlling nanoparticle mo ⁇ hology and allows the parameters of surface plasmon resonance (SPR) to be effectively tailored.
- SPR surface plasmon resonance
- the method of the invention produces silver nanoparticles with multiple plasmon bands, due to the presence of silver particles of non-spherical shape.
- the method allows for the controlled tuning of the SPR and consequently the systematic colour change of silver nanoparticles.
- the SPR of the nanoparticles can be tuned so that a wide range of particles of different optical properties can be prepared.
- the use of PVA as a stabilising agent provides for long term stability and storage of the nanomaterials.
- the invention provides for the large scale production of nanoparticles. It can be carried out in solution, it utilises commercially available reagents, it does not require lithographic equipment and the method does not require long reaction times. Synthesis of the nanoparticles may be carried out in an hour.
- silver nanoparticles of average size 20 nm as determined by transmission electron microscopy (TEM), with a variety of mo ⁇ hologies are prepared by a seeding method.
- the silver nanoparticles obtained by this seeding method exhibit a narrow particle size distribution of ⁇ 7 nm.
- Silver seed nanoparticles are prepared by sodium borohydride reduction of silver ions, in the presence of trisodium citrate. These seed nanoparticles are then added (along with ascorbic acid reducing agent) to a growth solution of silver ions and a polymeric capping agent, with molecular weight greater than 30 kDa, for example, poly (vinyl alcohol) or poly(vinylpyrollidone).
- the silver nanoparticles of the invention may show two peaks in their visible abso ⁇ tion spectra. The presence of more than one surface plasmon resonance is believed to be due to the presence of different silver nanoparticle mo ⁇ hologies.
- the shape of the nanoparticles is controlled by varying the reaction conditions.
- the different shapes produced through these variations in the reaction conditions allows the position of the position of second peak in the UV-Visible spectrum to be moved. This results in the preparation of silver nanoparticles of a range of colours, including red, purple and blue.Thus, the colour of the silver nanoparticles may be tuned by altering the conditions used to conduct the seeding method in order to vary their mo ⁇ hology in a controlled manner.
- Fig. 4 shows the electronic abso ⁇ tion spectra of samples A, B, C and D.
- Fig. 5 shows the electronic abso ⁇ tion spectrum of sample E..
- the size and shape of the nanoparticles was determined by transmission electron microscopy.
- the size of the nanoparticles samples A-E as determined from TEM images were:
- the predominant particle shape associated with each sample is shown in Fig 4(b).
- the predominant particle shape is triangular - 55 % of particles sampled show this mo ⁇ hology.
- Other particle shapes i.e. spheres, hexagons and rods are observed in smaller amounts, (22 %, 14 % and 9 % respectively).
- the predominant nanoparticle mo ⁇ hology was found to be highly dependent on the reaction conditions used, particularly PVA concentration.
- the presence of elemental silver was confirmed by Energy Dispersive X-ray analysis.
- nanoparticles that are produced by this method may have use in a number of applications as follows:
- SERS Surface enhanced raman scattering
- the high sensitivity of this technique is due to the enhanced Raman scattering exhibited by molecules that are adsorbed onto particular surfaces.
- the silver nanoparticles that are produced by the method of the invention can be used as the surfaces (substrates) onto which the analytes are adsorbed. This is because the nanoparticles absorb strongly at the excitation wavelength, 514 nm, which is used in this technique.
- the strong abso ⁇ tion of the nanoparticles at this wavelength shows enhanced optical nonlinearity. Materials with such enhanced, ultrafast nonlinear optical response are required for the development of photonic devices.
- the position of the surface plasmon resonance i.e. the wavelength at which it occurs
- the position of the surface plasmon resonance is sensitive to changes in the local environment of the nanoparticles. Therefore, changes in the plasmon band can be used to detect binding of other molecules to the nanoparticles and provide a method of biosensing.
- the nanoparticles may be used in catalysis since they have large surface- volume ratios and the generation of different nanoparticle mo ⁇ hologies would allow tailoring of the catalyst for different reactions.
- Figs, la and lb relate to spherical nanoparticles only.
- Figs. 2(a), 2(b) and 5 relate to a mixture of spherical, triangular and hexagonal nanoparticles.
- a mixture of spherical and cornered nanoparticles is useful since the cornered nanoparticles are more sensitive to changes in their environment than spherical ones because significantly higher amplitude SPR has been shown (20) to occur at corners on nanoparticles.
- the sha ⁇ er the corner on the nanoparticle the greater the increase in amplitude of the SPR.
- the ratio of the changes induced in SPR peaks of the two types of nanoparticles can provide important information for sensing.
- Figs. 3(a) and 3(b) relate to cornered nanoparticles e.g. a mixture of triangular and hexagonal nanoparticles only.
- the absence of an aboso ⁇ tion peak in the 410nm region indicates the absence of spherical nanoparticles.
- These cornered nanoparticles are especially advantageous due to their very high sensitivity.
- Figs. 8 and 9 demonstrate the enhanced sensitivity of silver nanoparticles over gold nanoparticles.
- the silver nanoparticles exhibit an 11 nm shift to the solvent dimethyl sulf oxide (DMSO) whereas a shift of only 0.5 nm is found in the case of gold.
- DMSO solvent dimethyl sulf oxide
- the silver nanop article-based sensor of the invention may be modified to detect any analyte of interest provided that a suitable receptor is prepared and adsorbed onto the available surface of the silver nanoparticles. It is envisaged that sensors having nanoparticles bearing, for example, biotin or carboxylic acid groups suitable for subsequent functionalisation may also be prepared. The end-user may then functionalise the sensor with an appropriate receptor to conduct a range of assays as required.
- Poly(vinyl alcohol) (PVA)-silver nanoparticles were typically prepared as follows: aqueous AgNO 3 (0.01 M, 0.25 ml) was added to aqueous PVA of molecular weight
- Example A Preparation of red silver nanoparticles
- Aqueous PVA mol. wt. 89 kD - 98 kD, 1% w/v, 10 ml
- aqueous AgNO 3 (0.01 M, 0.25 ml) were added to a reaction vessel.
- the mixture was heated to 40 2 C.
- Silver seed nanoparticles prepared according to example 1 0.1 ml
- ascorbic acid 0.1 M, 0.05 ml
- the silver nanoparticles were incubated at 40 -C for one hour, then transferred to a sample tube and stored in the dark at 4 2 C.
- Aqueous PVA (mol. wt. 89 kD - 98 kD, 2.5 % w/v, 10 ml) and aqueous AgNO 3
- Aqueous PVA (mol. wt. 89 kD - 98 kD, 5 % w/v, 10 ml) and aqueous AgNO 3 (0.01 M, 0.25 ml) were added to a reaction vessel. The mixture was heated to 40 2 C.
- Silver seed nanoparticles prepared according to example 1 (0.2 ml) and ascorbic acid (0.1 M, 0.05 ml) were added simultaneously - a colour change from colourless to blue was observed.
- the silver nanoparticles were incubated at 40 e C for one hour, then transferred to a sample tube and stored in the dark at 4 S C.
- Aqueous PVA (mol. wt. 89 kD - 98 kD, 5 % w/v, 10 ml) and aqueous AgNO 3 (0.01
- Aqueous PVA (mol. wt. 89 kD - 98 kD, 1 % w/v, 10 ml) and aqueous AgNO 3 (0.01 M, 0.25 ml) were added to a reaction vessel.
- Silver seed nanoparticles prepared according to example 1 (0.1 ml) were added to the mixture.
- the reaction vessel was placed at a distance of 60 cm from a xenon lamp (Oriel Xe, luminance 12 cd/m 2 ).
- Ascorbic acid (0.1 M, 0.05 ml) was added and the reaction vessel was shaken to ensure mixing. A colour change from colourless to red was observed after about 30 seconds. The silver nanoparticles were incubated, then transferred to a sample tube and stored in the dark at 4 2 C.
- Silver nanoparticles were prepared following the method described in example A except that the procedure was conducted in a darkroom. The abso ⁇ tion spectrum of this sample is shown in Fig 5.
- Silver nanoparticles were prepared at 40 S C according to the method described in example 2(i)B, but using 2.5 % (w/v) PVP as stabilizer. Using PVP of molecular weight 10 kD yielded nanoparticles having a single absorption peak at 410 nm; using PVP of molecular weight 55kD yielded nanoparticles having abso ⁇ tion peaks at 410 nm and 544 nm.
- Example 4 Deposition of a biotin layer on silver nanoparticles in two stages
- a solution of silver nanoparticle produced according to example 2 (having a silver content of 2.5 x 10 "4 M in water) and was incubated with a mixture of alkanethiol and mercapto-acid having a total concentration of 1 mM in ethanol at room temperature overnight, allowing an alkanethiol/mercapto-acid layer, most probably a monolayer, to form on the surface of the silver nanoparticles.
- the resulting silver nanoparticles bearing an alkanethiol/mercapto-acid layer were recovered by centrifuging.
- (+)-biotinyl-3,6- dioxaoctanediamine (EZ-LinkTM Biotin-PEO-amine, Pierce Biotechnology) was added to the alkanethiol/mercapto-acid-coated silver nanoparticles in the presence of l-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC, Pierce
- biotinylated nanoparticles bears receptors capable of binding selectively to analytes of interest, e.g.: streptavidin, anti-biotin etc.
- Example 5 Deposition of a biotinylated layer on silver nanoparticles in one stage
- Sulfosuccinimidyl-6'-(biotinamido)-6-hexanamido hexanoate (Sulfo-NHS-LC-LC- biotin, Pierce Biotechnology) was reacted with an aminoalkanethiol yielding a thiol- terminated biotin derivative.
- Silver nanoparticles produced according to example 2 were incubated with the biotin derivative in an aqueous buffer e.g.: 0.1 M MES(2- (N-Mo ⁇ holino)ethansulfonic acid ) at room temperature overnight, allowing a biotinylated layer, most probably a monolayer to form on the surface of the silver nanoparticles.
- the resulting product was recovered by centrifuging and resuspended in water or aqueous buffer.
- the biotinylated nanoparticles thus obtained bear receptors capable of binding selectively to analytes of interest, e.g.: streptavidin, anti-biotin.
- a biotinylating solution was prepared by adding ImM (+)-Biotinyl-3,6- dioxaoctanediamine to an equal volume of lmg/ml l-ethyl-3-(3- dimethylaminopropyDcarbodiimide hydrochloride (EDC) in an aqueous buffer e.g.: 0.1 M MES(2-(N-M ⁇ holino)ethansulfonic acid ), pH 5.5.
- EDC dimethylaminopropyDcarbodiimide hydrochloride
- a known volume of a solution of nanoparticles produced according to example 2 was centrifuged and the supernatant removed.
- biotinylating solution An equal volume of biotinylating solution was added to the silver nanoparticles and the pellet is was resuspended through shaking or use of a vortex. The suspension was is stirred gently and allowed incubate for up to 48 hours at room temperature. The resulting biotinylated silver nanoparticles were recovered by centrifuging and resuspended in water or aqueous buffer.
- BSA Bovine Serum Albumin
- 0.2ml of lOmg/ml Bovine Serum Albumin (BSA) in aqueous buffer e.g.: 0.1 M MES, pH 5.5
- aqueous buffer e.g.: 0.1 M MES, pH 5.5
- This solution was added to 0.2 ml of a solution of silver nanoparticles produced according to example 2 and incubated for between 2 and 24 hours at room temperature. After incubation, the BSA-coated silver nanoparticles were recovered by centrifuging and resuspended in water or aqueous buffer.
- a solution of streptavidin in water or aqueous buffer e.g. 0.1 M MES, pH 5.5
- a concentration ranging from 10 ⁇ g/ml to 10 mg/ml was added to an equal volume of a solution of silver nanoparticles produced according to example 2.
- the mixture was stirred gently and incubated at room temperature for between one and 24 hours. After incubation, the streptavidin-coated silver nanoparticles were recovered by centrifuging and resuspended in water or aqueous buffer.
- 0.2 ml of 10 mg/ml streptavidin in aqueous buffer (e.g.: 0.1 M MES, pH 5.5) was added to an equal volume of 1 mg/ml EDC hydrochloride in the same buffer.
- This solution was added to 0.2 ml of a solution of silver nanoparticles produced according to example 2 and incubated for between 2 and 24 hours at room temperature. After incubation, the streptavidin-coated silver nanoparticles were recovered by centrifuging and resuspended in water or aqueous buffer.
- Biotinylated silver nanoparticles were prepared as described in examples 4-6 using solutions of biotin at concentrations ranging from 1 mM to 1 nM, more preferably 0.1 mM to 0.01 mM. Streptavidin was added to each sample at concentrations ranging from 1 mg/ml to 100 pg/ml. In all cases, detection of streptavidin was observed as a shift of, the SPR spectral peaks accompanied by a change in the ratio of the relative intensity of the SPR bands for nanoparticles having more than one SPR peak. No further shift was apparent in the spectrum after 24 hours.
- Biotinylated nanoparticles prepared as described in examples 4-6, but using a higher concentration of silver, were deposited on a nitrocellulose membrane whose pore size was chosen such that dilute solutions of the analyte of interest could pass through the membrane while the biotinylated nanoparticles remain trapped in its structure. Successive additions of biotinylated nanoparticles may be made to the membrane to obtain an intensely coloured region.
- a solution of streptavidin was passed through the membrane.
- the streptavidin bound to the biotin present on the nanoparticles causing a loss of intensity in their spectrum.
- a positive test result was indicated by observing a loss of colour on the membrane.
- the test may be modified to detect any analyte of interest where a suitable receptor is adsorbed onto the available surface of the silver nanoparticles in the manner described in the examples above.
- 0.5 ml of a solution of silver nanoparticles prepared according to example 2 were centrifuged and the supernatant removed.
- 5 mg/ml EDC and 0.5 mg/ml domoic acid in aqueous buffer, e.g.: PBS was added to the silver nanoparticle pellet and the whole was resuspended using a vortex.
- the suspension was stirred gently and incubated at room temperature for 3 hours.
- 25 ⁇ l of 10 % w/v human serum albumin (HSA) was added and the whole stirred for another 10 minutes.
- the suspension was centrifuged, the supernatant removed and the pellet resuspended in PBS.
- 3-4 drops of the resuspended silver nanoparticles were added to lateral flow strips having rabbit anti- mouse as the control line and domoic acid conjugated to BSA as the test line.
- the lateral flow strip were stood in a 0.5 M solution of surfactant, e.g: Tween. After allowing the solution to rise to the top of the lateral flow strip, the strip was removed from the solution and examined for the presence of control and test lines.
- aqueous buffer e.g.: 0.1 M MES, pH 5.5.
- IgG coated silver nanoparticles were recovered by centrifuging and re-suspended in water or aqueous buffer.
- Anti-IgG was added to each aliquot at concentrations ranging from 1 mg/ml to 100 pg/ml. In all cases, detection of streptavidin was observed as a shift of, the SPR spectral peaks accompanied by a change in the ratio of the relative intensity of the SPR bands for nanoparticles having more than one SPR peak. No further shift was apparent in the spectrum after 24 hours.
- a device was constructed as illustrated in Fig. 27 consisting of a LED, sample cuvette, photodiode detector and voltmeter.
- a LED having 100 nm spectral width and peak emission at 490 nm was used.
- 0.4 ml of a solution of silver nanoparticles prepared according to example 2 was added to the sample cuvette, placed in the optical path of the LED and the voltage output from the photodiode recorded.
- 0.1 ml DMSO was added to the sample cuvette and the voltage output from the photodiode recorded again. A change in voltage of 20 mV was observed in response to the presence of DMSO.
- the handheld device may produce a quantitative response to the presence of a target analyte whereby an observed change in voltage indicates the presence of the analyte, or it may produce a qualitative response whereby the change in voltage observed is proportional to the concentration of analyte present.
- a silver nanoparticle sensor of the invention may be deposited on a porous membrane, for example nitrocellulose, whose pore size was chosen such that dilute solutions of the analyte of interest could pass through the membrane while the biotinylated nanoparticles remain trapped in its structure. Successive additions of nanoparticles may be made to the membrane to obtain an intensely coloured region.
- a solution of the sample matrix is passed through the membrane. If the target analyte is present in the matrix, it may bind to the sensor, causing a detectable change in their spectrum. Most preferably, this detectable change is a colour change visible to the naked eye.
- the assay kit may produce a quantitative response to the presence of a target analyte whereby an observed colour change indicates the presence of the analyte, or it may produce a qualitative response whereby the extent of the colour change observed is proportional to the concentration of analyte present.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002520449A CA2520449A1 (en) | 2003-03-28 | 2004-03-29 | Sensor and silver nanoparticles prepared with an aqueous polymeric stabilizer |
AU2004223618A AU2004223618A1 (en) | 2003-03-28 | 2004-03-29 | Sensor for detecting an analyte using silver nanoparticles |
NZ542824A NZ542824A (en) | 2003-03-28 | 2004-03-29 | Sensor for detecting an analyte using silver nanoparticles |
JP2006507571A JP4787938B2 (en) | 2003-03-28 | 2004-03-29 | Detecting sensor using silver nanoparticles |
EP04724093.2A EP1608975B1 (en) | 2003-03-28 | 2004-03-29 | Sensor for detecting an analyte using silver nanoparticles |
US11/235,053 US8263418B2 (en) | 2003-03-28 | 2005-09-27 | Sensors for detecting an analyte using silver nanoparticles |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE2003/0234 | 2003-03-28 | ||
IE20030234 | 2003-03-28 | ||
US48301003P | 2003-06-27 | 2003-06-27 | |
US60/483,010 | 2003-06-27 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/235,053 Continuation US8263418B2 (en) | 2003-03-28 | 2005-09-27 | Sensors for detecting an analyte using silver nanoparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004086044A1 true WO2004086044A1 (en) | 2004-10-07 |
Family
ID=33100074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IE2004/000047 WO2004086044A1 (en) | 2003-03-28 | 2004-03-29 | Sensor for detecting an analyte using silver nanoparticles |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1608975B1 (en) |
AU (1) | AU2004223618A1 (en) |
CA (1) | CA2520449A1 (en) |
NZ (1) | NZ542824A (en) |
WO (1) | WO2004086044A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006131400A1 (en) * | 2005-06-10 | 2006-12-14 | Gilupi Gmbh | Diagnostic-nanosensor and its use in medicine |
JP2007010648A (en) * | 2005-06-01 | 2007-01-18 | Canon Inc | Localized plasmon resonance sensor |
WO2007058173A1 (en) * | 2005-11-15 | 2007-05-24 | Kyoto University | Metal nanoplate-fixed substrate and method for manufacture thereof |
EP1811302A1 (en) * | 2006-01-19 | 2007-07-25 | Topass Gmbh | Diagnostic nanosensor and its use in medicine |
JP2007327129A (en) * | 2006-06-09 | 2007-12-20 | Fuji Xerox Co Ltd | Silver triangular pyramid particle and method of manufacturing the same |
WO2010040034A2 (en) * | 2008-10-03 | 2010-04-08 | The Board Of Trustees Of The University Of Illinois | Metal nanoparticle inks |
EP2574927A1 (en) * | 2011-09-28 | 2013-04-03 | Fujifilm Corporation | Method for measuring substance to be measured using fluorescent particles, test subsance measurement chip, and test subsance measurement kit |
WO2014058904A1 (en) * | 2012-10-11 | 2014-04-17 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
US8802154B2 (en) | 2010-08-27 | 2014-08-12 | Sienna Labs, Inc. | Thermal treatment of a pilosebaceous unit with nanoparticles |
US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102841061B (en) * | 2012-09-14 | 2015-06-03 | 中国科学院宁波材料技术与工程研究所 | Method for detecting nickelous ions |
GB201709503D0 (en) * | 2017-06-15 | 2017-08-02 | Method and device for assay improvement |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002087749A1 (en) * | 2001-04-30 | 2002-11-07 | Postech Foundation | Colloid solution of metal nanoparticles, metal-polymer nanocomposites and methods for preparation thereof |
EP1321761A1 (en) * | 2001-12-21 | 2003-06-25 | Interuniversitair Micro-Elektronica Centrum | Method of detecting an analyte |
-
2004
- 2004-03-29 CA CA002520449A patent/CA2520449A1/en not_active Abandoned
- 2004-03-29 WO PCT/IE2004/000047 patent/WO2004086044A1/en active Application Filing
- 2004-03-29 EP EP04724093.2A patent/EP1608975B1/en not_active Expired - Lifetime
- 2004-03-29 AU AU2004223618A patent/AU2004223618A1/en not_active Abandoned
- 2004-03-29 NZ NZ542824A patent/NZ542824A/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002087749A1 (en) * | 2001-04-30 | 2002-11-07 | Postech Foundation | Colloid solution of metal nanoparticles, metal-polymer nanocomposites and methods for preparation thereof |
EP1321761A1 (en) * | 2001-12-21 | 2003-06-25 | Interuniversitair Micro-Elektronica Centrum | Method of detecting an analyte |
Non-Patent Citations (4)
Title |
---|
CHOI S-H ET AL: "Interaction between the surface of the silver nanoparticles prepared by gamma-irradiation and organic molecules containing thiol group", RADIATION PHYSICS AND CHEMISTRY, ELSEVIER SCIENCE PUBLISHERS BV., AMSTERDAM, NL, vol. 67, no. 3-4, June 2003 (2003-06-01), pages 517 - 521, XP004427014, ISSN: 0969-806X * |
FREDERIX F ET AL: "BIOSENSING BASED ON LIGHT ABSORPTION OF NANOSCALED GOLD AND SILVER PARTICLES", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 75, no. 24, 15 December 2003 (2003-12-15), pages 6894 - 6900, XP001047366, ISSN: 0003-2700 * |
HAES A J ET AL: "A nanoscale optical biosensor: sensitivity and selectivity of an approach based on the localized surface plasmon resonance spectroscopy of triangular silver nanoparticles", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 124, no. 35, 2002, pages 10596 - 10604, XP002237025, ISSN: 0002-7863 * |
OLDENBURG STEVEN J ET AL: "Base pair mismatch recognition using plasmon resonant particle labels.", ANALYTICAL BIOCHEMISTRY, vol. 309, no. 1, 1 October 2002 (2002-10-01), pages 109 - 116, XP002283865, ISSN: 0003-2697 (ISSN print) * |
Cited By (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007010648A (en) * | 2005-06-01 | 2007-01-18 | Canon Inc | Localized plasmon resonance sensor |
US8197756B2 (en) | 2005-06-10 | 2012-06-12 | Gilupi Gmbh | Diagnostic-nanosensor and its use in medicine |
CN101305280B (en) * | 2005-06-10 | 2012-10-10 | 吉卢比有限公司 | Diagnostic-nanosensor and its use in medicine |
US8846580B2 (en) | 2005-06-10 | 2014-09-30 | Gilupi Gmbh | Diagnostic nanosensor and its use in medicine |
WO2006131400A1 (en) * | 2005-06-10 | 2006-12-14 | Gilupi Gmbh | Diagnostic-nanosensor and its use in medicine |
WO2007058173A1 (en) * | 2005-11-15 | 2007-05-24 | Kyoto University | Metal nanoplate-fixed substrate and method for manufacture thereof |
EP1811302A1 (en) * | 2006-01-19 | 2007-07-25 | Topass Gmbh | Diagnostic nanosensor and its use in medicine |
US8790505B2 (en) | 2006-06-09 | 2014-07-29 | Fuji Xerox Co., Ltd. | Method for manufacturing silver triangular pyramid particles and silver triangular pyramid particles |
JP2007327129A (en) * | 2006-06-09 | 2007-12-20 | Fuji Xerox Co Ltd | Silver triangular pyramid particle and method of manufacturing the same |
WO2010040034A2 (en) * | 2008-10-03 | 2010-04-08 | The Board Of Trustees Of The University Of Illinois | Metal nanoparticle inks |
WO2010040034A3 (en) * | 2008-10-03 | 2010-09-02 | The Board Of Trustees Of The University Of Illinois | Metal nanoparticle inks |
US7922939B2 (en) | 2008-10-03 | 2011-04-12 | The Board Of Trustees Of The University Of Illinois | Metal nanoparticle inks |
US8834933B2 (en) | 2010-08-27 | 2014-09-16 | Sienna Labs, Inc. | Thermal treatment of acne with nanoparticles |
US10537640B2 (en) | 2010-08-27 | 2020-01-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
US8821941B2 (en) | 2010-08-27 | 2014-09-02 | Sienna Labs, Inc. | Hair removal with nanoparticles |
US8821940B2 (en) | 2010-08-27 | 2014-09-02 | Sienna Labs, Inc. | Thermal treatment of the skin surface with nanoparticles |
US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
US9446126B2 (en) | 2010-08-27 | 2016-09-20 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of acne with coated metal nanoparticles |
US8895071B1 (en) | 2010-08-27 | 2014-11-25 | Sienna Labs, Inc. | Thermal treatment of a pilosebaceous unit with coated metal nanoparticles |
US8906418B1 (en) | 2010-08-27 | 2014-12-09 | Sienna Labs, Inc. | Thermal treatment of a pilosebaceous unit with nanoparticles with coatings that facilitate selective removal from the skin surface |
US11826087B2 (en) | 2010-08-27 | 2023-11-28 | Coronado Aesthetics, Llc | Compositions and methods for thermal skin treatment with metal nanoparticles |
US9061056B2 (en) | 2010-08-27 | 2015-06-23 | Sienna Labs, Inc. | Compositions and methods for targeted thermomodulation |
US11419937B2 (en) | 2010-08-27 | 2022-08-23 | Coronado Aesthetics, Llc | Delivery of nanoparticles |
US8802154B2 (en) | 2010-08-27 | 2014-08-12 | Sienna Labs, Inc. | Thermal treatment of a pilosebaceous unit with nanoparticles |
US9421259B2 (en) | 2010-08-27 | 2016-08-23 | Sienna Biopharmaceuticals, Inc. | Hair removal with coated metal nanoparticles |
US9421261B2 (en) | 2010-08-27 | 2016-08-23 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of the skin surface with nanoparticles with coatings that facilitate selective removal from the skin surface |
US9421260B2 (en) | 2010-08-27 | 2016-08-23 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of acne with nanoparticles with coatings that facilitate selective removal from the skin surface |
US9427467B2 (en) | 2010-08-27 | 2016-08-30 | Sienna Biopharmaceuticals, Inc. | Hair removal with metal nanoparticles in surfactant containing solutions |
US9433678B2 (en) | 2010-08-27 | 2016-09-06 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of acne with metal nanoparticles in surfactant containing solutions |
US9433677B2 (en) | 2010-08-27 | 2016-09-06 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of a pilosebaceous unit with metal nanoparticles in surfactant containing solutions |
US9433676B2 (en) | 2010-08-27 | 2016-09-06 | Sienna Biopharmaceuticals, Inc. | Hair removal with nanoparticles with coatings that facilitate selective removal from the skin surface |
US9439965B2 (en) | 2010-08-27 | 2016-09-13 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of the skin surface with metal nanoparticles in surfactant containing solutions |
US9439964B2 (en) | 2010-08-27 | 2016-09-13 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of the skin surface with coated metal nanoparticles |
EP2574927A1 (en) * | 2011-09-28 | 2013-04-03 | Fujifilm Corporation | Method for measuring substance to be measured using fluorescent particles, test subsance measurement chip, and test subsance measurement kit |
WO2014058904A1 (en) * | 2012-10-11 | 2014-04-17 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
US9526745B2 (en) | 2012-10-11 | 2016-12-27 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
RU2646809C2 (en) * | 2012-10-11 | 2018-03-07 | Нанокомпозикс, Инк. | Silver nanoplates compositions and methods |
CN108480620A (en) * | 2012-10-11 | 2018-09-04 | 纳诺康波西克斯公司 | Nano silver piece composition and method |
US9249334B2 (en) | 2012-10-11 | 2016-02-02 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
US10688126B2 (en) | 2012-10-11 | 2020-06-23 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
KR102154207B1 (en) | 2012-10-11 | 2020-09-10 | 나노콤포식스, 인크. | Silver nanoplate compositions and methods |
AU2020204436B2 (en) * | 2012-10-11 | 2022-07-28 | Coronado Aesthetics, Llc | Silver nanoplate compositions and methods |
US9212294B2 (en) | 2012-10-11 | 2015-12-15 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
US11583553B2 (en) | 2012-10-11 | 2023-02-21 | Nanocomposix, Llc | Silver nanoplate compositions and methods |
KR20150066589A (en) * | 2012-10-11 | 2015-06-16 | 나노콤포식스, 인크. | Silver nanoplate compositions and methods |
US12029831B2 (en) | 2012-10-11 | 2024-07-09 | Coronado Aesthetics, Llc | Silver nanoplate compositions and methods |
Also Published As
Publication number | Publication date |
---|---|
EP1608975B1 (en) | 2013-06-19 |
EP1608975A1 (en) | 2005-12-28 |
NZ542824A (en) | 2008-12-24 |
AU2004223618A1 (en) | 2004-10-07 |
CA2520449A1 (en) | 2004-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8263418B2 (en) | Sensors for detecting an analyte using silver nanoparticles | |
Doering et al. | SERS as a foundation for nanoscale, optically detected biological labels | |
Haes et al. | Using solution-phase nanoparticles, surface-confined nanoparticle arrays and single nanoparticles as biological sensing platforms | |
Abalde-Cela et al. | Recent progress on colloidal metal nanoparticles as signal enhancers in nanosensing | |
Seydack | Nanoparticle labels in immunosensing using optical detection methods | |
Nath et al. | Label free colorimetric biosensing using nanoparticles | |
Joshi et al. | Improved localized surface plasmon resonance biosensing sensitivity based on chemically-synthesized gold nanoprisms as plasmonic transducers | |
Long et al. | Localized surface plasmon resonance based nanobiosensors | |
KR101195957B1 (en) | Combinational surface-enhanced raman scattering probe and method for detecting target substance by using the same | |
US7727776B2 (en) | Core-shell nanoparticles for detection based on SERS | |
Wang et al. | Design and performances of immunoassay based on SPR biosensor with Au/Ag alloy nanocomposites | |
Pekdemir et al. | Ultrasensitive and selective homogeneous sandwich immunoassay detection by Surface Enhanced Raman Scattering (SERS) | |
Babamiri et al. | Potential-resolved electrochemiluminescence immunoassay for simultaneous determination of CEA and AFP tumor markers using dendritic nanoclusters and Fe 3 O 4@ SiO 2 nanoparticles | |
EP1608975B1 (en) | Sensor for detecting an analyte using silver nanoparticles | |
Qi et al. | One-step homogeneous non-stripping chemiluminescence metal immunoassay based on catalytic activity of gold nanoparticles | |
Li et al. | SERS quantitative analysis of trace ferritin based on immunoreaction regulation of graphene oxide catalytic nanogold reaction | |
Narayanan | Nanoparticles of different shapes for biosensor applications | |
Xiaoyan et al. | A sensitive, switchable and biocompatible surface enhanced Raman scattering-fluorescence dual mode probe using bipyramid gold nanocrystal-gold nanoclusters for high-throughput biodetection | |
Pan et al. | A novel FRET immunosensor for rapid and sensitive detection of dicofol based on bimetallic nanoclusters | |
Huang et al. | A localized surface plasmon resonance biosensor based on integrated controllable Au 2 S/AuAgS-coated gold nanorods composite | |
Pourali et al. | Ultra-sensitive facile CdS nanocrystals-based electrochemical biosensor to detect myocardial infarction marker troponin | |
IE20040203A1 (en) | Silver nanoparticle sensor | |
Huang et al. | Label-free optical biosensors based on Au2S-coated gold nanorods | |
Imbraguglio et al. | Nanometrology | |
Mei et al. | Gold nanorod array biochip for label-free, multiplexed biological detection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2520449 Country of ref document: CA Ref document number: 11235053 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006507571 Country of ref document: JP Ref document number: 2004223618 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004724093 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 542824 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2004223618 Country of ref document: AU Date of ref document: 20040329 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004223618 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004724093 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11235053 Country of ref document: US |